OneCell Diagnostics raises $16 million in round led by Celesta Capital, others
OneCell Diagnostics raised $16 million in an oversubscribed series A funding round led by Celesta Capital.
Other participants in the funding round included Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures.
The company, which has developed cutting-edge technology for precision oncology liquid biopsy diagnostics and is headquartered in India and Silicon Valley, said the funding will be used to advance its vision of democratising precision oncology through cancer diagnostic testing that is more accessible, actionable, and affordable.
With this funding, it will expand to the US market with its next-generation liquid biopsy test called OncoIndx Alfa, which detects circulating tumour cells which offer rich biomarkers that advance precision diagnosis and treatment of cancer for use cases including treatment response monitoring, disease progression, recurrence, and more.
Further, Celesta Capital founding managing partner Michael Marks and Nobel Laureate and Celesta Capital senior advisor James Rothman will join the OneCell board of directors.
Web Development
Mastering Full Stack Development: From Frontend to Backend Excellence
By — Metla Sudha Sekhar, IT Specialist and Developer
Web Development
C++ Fundamentals for Absolute Beginners
By — Metla Sudha Sekhar, IT Specialist and Developer
Finance
AI and Generative AI for Finance
By — Hariom Tatsat, Vice President- Quantitative Analytics at Barclays
Astrology
Vastu Shastra Course
By — Sachenkumar Rai, Vastu Shashtri
Data Science
SQL for Data Science along with
